443 related articles for article (PubMed ID: 21263135)
1. Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies.
van Nes SI; Vanhoutte EK; van Doorn PA; Hermans M; Bakkers M; Kuitwaard K; Faber CG; Merkies IS
Neurology; 2011 Jan; 76(4):337-45. PubMed ID: 21263135
[TBL] [Abstract][Full Text] [Related]
2. Improving fatigue assessment in immune-mediated neuropathies: the modified Rasch-built fatigue severity scale.
van Nes SI; Vanhoutte EK; Faber CG; Garssen M; van Doorn PA; Merkies IS;
J Peripher Nerv Syst; 2009 Dec; 14(4):268-78. PubMed ID: 20021568
[TBL] [Abstract][Full Text] [Related]
3. Correlation of the patient's reported outcome Inflammatory-RODS with an objective metric in immune-mediated neuropathies.
Draak TH; Gorson KC; Vanhoutte EK; van Nes SI; van Doorn PA; Cornblath DR; van den Berg LH; Faber CG; Merkies IS;
Eur J Neurol; 2016 Jul; 23(7):1248-53. PubMed ID: 27129110
[TBL] [Abstract][Full Text] [Related]
4. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
[TBL] [Abstract][Full Text] [Related]
5. Changing outcome in inflammatory neuropathies: Rasch-comparative responsiveness.
Draak TH; Vanhoutte EK; van Nes SI; Gorson KC; Van der Pol WL; Notermans NC; Nobile-Orazio E; Léger JM; Van den Bergh PY; Lauria G; Bril V; Katzberg H; Lunn MP; Pouget J; van der Kooi AJ; Hahn AF; Doorn PA; Cornblath DR; van den Berg LH; Faber CG; Merkies IS;
Neurology; 2014 Dec; 83(23):2124-32. PubMed ID: 25378677
[TBL] [Abstract][Full Text] [Related]
6. Defective Fas-mediated T-cell apoptosis predicts acute onset CIDP.
Comi C; Osio M; Ferretti M; Mesturini R; Cappellano G; Chiocchetti A; Carecchio M; Nascimbene C; Varrasi C; Cantello R; Mariani C; Monaco F; Dianzani U
J Peripher Nerv Syst; 2009 Jun; 14(2):101-6. PubMed ID: 19691532
[TBL] [Abstract][Full Text] [Related]
7. IL-8 as a potential biomarker in Guillain-Barre Syndrome.
Breville G; Lascano AM; Roux-Lombard P; Lalive PH
Eur Cytokine Netw; 2019 Dec; 30(4):130-134. PubMed ID: 32096474
[TBL] [Abstract][Full Text] [Related]
8. Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barré syndrome.
Odaka M; Yuki N; Hirata K
J Neurol; 2003 Aug; 250(8):913-6. PubMed ID: 12928908
[TBL] [Abstract][Full Text] [Related]
9. [Inflammatory polyneuropathies can be treated successfully].
Press R; Askmark H; Andersen O
Lakartidningen; 2012 May 9-15; 109(19):950-4. PubMed ID: 22734259
[No Abstract] [Full Text] [Related]
10. Guillain Barré syndrome and other immune mediated neuropathies: diagnosis and classification.
Eldar AH; Chapman J
Autoimmun Rev; 2014; 13(4-5):525-30. PubMed ID: 24434363
[TBL] [Abstract][Full Text] [Related]
11. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy.
Van den Bergh PY; Piéret F
Muscle Nerve; 2004 Apr; 29(4):565-74. PubMed ID: 15052622
[TBL] [Abstract][Full Text] [Related]
12. Does ability to walk reflect general functionality in inflammatory neuropathies?
Draak TH; Gorson KC; Vanhoutte EK; van Nes SI; van Doorn PA; Cornblath DR; van den Berg LH; Faber CG; Merkies IS;
J Peripher Nerv Syst; 2016 Jun; 21(2):74-81. PubMed ID: 26968437
[TBL] [Abstract][Full Text] [Related]
13. Distinguishing acute-onset CIDP from Guillain-Barré syndrome with treatment related fluctuations.
Ruts L; van Koningsveld R; van Doorn PA
Neurology; 2005 Jul; 65(1):138-40. PubMed ID: 16009902
[TBL] [Abstract][Full Text] [Related]
14. Quality of life in inflammatory neuropathies: the IN-QoL.
Draak THP; Faber CG; Merkies ISJ;
J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):256-262. PubMed ID: 28986470
[TBL] [Abstract][Full Text] [Related]
15. Sural nerve T cells in demyelinating polyneuropathy associated with monoclonal gammopathy.
Eurelings M; Notermans NC; Wokke JH; Bosboom WM; Van den Berg LH
Acta Neuropathol; 2002 Feb; 103(2):107-14. PubMed ID: 11810175
[TBL] [Abstract][Full Text] [Related]
16. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Zhang HL; Zhang XM; Mao XJ; Deng H; Li HF; Press R; Fredrikson S; Zhu J
Acta Neurol Scand; 2012 Feb; 125(2):129-35. PubMed ID: 21434877
[TBL] [Abstract][Full Text] [Related]
17. Immune-mediated neuropathies.
Kiefer R; Kieseier BC; Hartung HP
Adv Neurol; 2002; 88():111-31. PubMed ID: 11908221
[No Abstract] [Full Text] [Related]
18. Increased circulating T cell reactivity to GM1 ganglioside in patients with Guillain-Barré syndrome.
Csurhes PA; Sullivan AA; Green K; Greer JM; Pender MP; McCombe PA
J Clin Neurosci; 2005 May; 12(4):409-15. PubMed ID: 15925771
[TBL] [Abstract][Full Text] [Related]
19. [Recent aspects of acute and chronic inflammatory polyneuropathies: Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
Pascual-Pascual SI
Rev Neurol; 2002 Aug 1-15; 35(3):269-76. PubMed ID: 12235589
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and therapeutic challenges in chronic inflammatory demyelinating polyneuropathy and other immune-mediated neuropathies.
Magy L; Mathis S; Vallat JM
Curr Opin Crit Care; 2011 Apr; 17(2):101-5. PubMed ID: 21157311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
